| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,581 |
21,219 |
$862K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,253 |
3,231 |
$267K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,278 |
3,262 |
$256K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,803 |
2,789 |
$248K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16,971 |
9,427 |
$183K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,316 |
12,751 |
$182K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,630 |
1,617 |
$125K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,242 |
1,214 |
$54K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,426 |
1,889 |
$50K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,409 |
3,393 |
$28K |
| 90461 |
|
2,744 |
2,321 |
$20K |
| 92551 |
|
1,507 |
1,500 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,145 |
1,111 |
$14K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
273 |
265 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
206 |
204 |
$12K |
| 99381 |
|
94 |
94 |
$8K |
| 96160 |
|
3,127 |
3,113 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
237 |
233 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,093 |
1,061 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
41 |
40 |
$957.70 |
| 83655 |
|
62 |
62 |
$694.95 |
| 81003 |
|
374 |
350 |
$691.18 |
| 83051 |
|
115 |
115 |
$472.54 |
| 36410 |
|
72 |
72 |
$303.34 |
| 94664 |
|
160 |
155 |
$176.03 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
137 |
137 |
$101.50 |
| 90686 |
|
3,002 |
2,985 |
$4.75 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
82 |
82 |
$3.79 |
| 90697 |
|
618 |
615 |
$3.13 |
| 90677 |
|
505 |
499 |
$2.72 |
| 90619 |
|
362 |
355 |
$2.28 |
| 90734 |
|
737 |
736 |
$0.75 |
| 90620 |
|
179 |
179 |
$0.26 |
| 90651 |
|
1,332 |
1,328 |
$0.26 |
| 90715 |
|
431 |
430 |
$0.24 |
| 90710 |
|
1,166 |
1,162 |
$0.11 |
| 90670 |
|
1,602 |
1,601 |
$0.10 |
| 90633 |
|
1,292 |
1,283 |
$0.10 |
| 90661 |
|
203 |
203 |
$0.04 |
| 90648 |
|
626 |
625 |
$0.01 |
| 90681 |
|
102 |
102 |
$0.01 |
| 90723 |
|
251 |
251 |
$0.01 |
| 90700 |
|
347 |
345 |
$0.00 |
| 90647 |
|
115 |
115 |
$0.00 |
| 90696 |
|
454 |
453 |
$0.00 |
| 90680 |
|
642 |
637 |
$0.00 |
| 90698 |
|
200 |
198 |
$0.00 |
| 90656 |
|
280 |
278 |
$0.00 |